Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q3 2025 · 10-Q
Revenue$425.86K$425.86K+1,975.5% vs Q3 2024 Net Income-$1.43M-$1.43MN/M vs Q3 2024 EPS Diluted-$0.83-$0.83N/M vs Q3 2024 Gross Profit$254,463+1,523.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,433,756N/M Margins · derivedGross margin59.8%−16.7 pt vs Q3 2024
Operating margin-345.4%+6574.0 pt vs Q3 2024
Net margin-335.7%+13692.6 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end